Humes v. Clinton, No. 63436
Court | United States State Supreme Court of Kansas |
Writing for the Court | HERD |
Citation | 792 P.2d 1032,246 Kan. 590 |
Parties | , 58 USLW 2731, Prod.Liab.Rep. (CCH) P 12,532 Brenda HUMES and Bennie Humes, Appellees/Cross-appellants, v. Dale L. CLINTON, M.D.; Dale L. Clinton, M.D., P.A.; Appellants/Cross-appellees, and ALZA Corporation, Appellant. |
Decision Date | 25 May 1990 |
Docket Number | No. 63436 |
Page 1032
(CCH) P 12,532
v.
Dale L. CLINTON, M.D.; Dale L. Clinton, M.D., P.A.;
Appellants/Cross-appellees,
and
ALZA Corporation, Appellant.
Page 1033
1. An unborn, nonviable fetus is not a "person" within the definition of the wrongful death act and is incapable of bringing an action on its own behalf. A nonviable fetus, incapable of independent life, is not a distinct entity; rather, its life is an integral part of its mother's life. Therefore, viability is an appropriate condition precedent to liability in a wrongful death action under K.S.A. 60-1901.
2. No survival action may be maintained to recover for alleged pain and suffering of an unborn, nonviable fetus.
3. A medical negligence claim accrues at the time of the occurrence of the act giving rise to the cause of action, unless the fact of the injury is not reasonably ascertainable until a later date. K.S.A. 60-513(c).
4. Recovery for emotional distress caused by a physician's failure to warn about possible physical and psychological consequences of obtaining an abortion is barred where no physical injury occurs. Thus, under the facts of this case, there is no fact of injury to be reasonably ascertained at a later date and the K.S.A. 60-513 two-year statute of limitations controls.
5. Manufacturers of prescription drugs have a duty to warn of dangerous
Page 1034
side effects and risks associated with the use of such drugs. The learned intermediary rule, however, relieves manufacturers of the duty to warn patients directly. Thus, where the manufacturer of an intrauterine device (IUD) adequately warns the physician of the risk of pregnancy and other risks associated with its use, the manufacturer is not liable for failure to warn the patient directly of risks associated with use of its IUD.6. The test to determine adequacy of a manufacturer's warning is reasonableness under the circumstances. Under the facts of this case, expert medical testimony that a manufacturer's[246 Kan. 591] warning to a physician concerning risk of pregnancy is adequate satisfies that test.
Cynthia J. Sheppeard, of Fisher, Heck & Cavanaugh, P.A., of Topeka, argued the cause and was on the briefs for appellant ALZA Corp.
Thomas E. Wright, and C. Steven Rarrick, of Davis, Wright, Unrein, Hummer & McCallister, of Topeka, were on the briefs for appellant/cross-appellee Dale L. Clinton, M.D.
John W. McClelland, of Wirken & King, P.C., of Kansas City, Mo., argued the cause, and Shelley Hickman Clark, of Lawrence, was with him on the briefs for appellees/cross-appellants.
HERD, Justice:
This is a medical malpractice and products liability case brought by Brenda and Bennie Humes on behalf of their nonviable fetus, as heirs at law of the fetus, and individually against Dale L. Clinton, M.D., and ALZA Corporation. Appellants Clinton and ALZA Corporation have perfected an interlocutory appeal of the district court's ruling denying them summary judgment on appellees Humes' claim for wrongful death, pain and suffering, strict liability and negligence per se. Appellees Humes cross-appeal the district court ruling granting summary judgment to Dr. Clinton on Brenda Humes' claim for emotional and physical injuries resulting from a previous abortion.
In reviewing a summary judgment, we must consider the record in the light most favorable to the party against whom summary judgment was entered. Mick v. Mani, 244 Kan. 81, 83, 766 P.2d 147 (1988); Johnston v. Elkins, 241 Kan. 407, 736 P.2d 935 (1987). The district court found the following facts uncontroverted or most favorable to the Humes:
1. Defendant ALZA Corporation (ALZA) is the manufacturer of an intrauterine contraceptive device (IUD) known as the Progestasert Intrauterine Progesterone Contraceptive System (IPCS). The IPCS is a T-shaped IUD with progesterone (a female hormone) in the vertical stem which is released over time. The IPCS is inserted by a physician into the patient's uterus for purposes of contraception.
2. The IPCS is approved by the Food and Drug Administration (FDA) for use for 12 months, with replacement recommended [246 Kan. 592] after that time. The physician information sheet prepared by ALZA states that the physician "should" provide the patient the patient information sheet and discuss with the patient the use of the IPCS. The physician information sheet and patient information sheet provide notice that pregnancy can occur with use of the IPCS and that for continued protection the system must be replaced after twelve months of use because the "contraceptive effectiveness of the system is retained for one year."
3. Brenda Humes had an IPCS inserted by Dr. Clinton on June 4, 1985.
4. Even though Dr. Clinton knew the IPCS was recommended for replacement after one year, he did not inform Brenda Humes of this nor did he give the patient information sheet prepared by ALZA to her.
5. Instead, Dr. Clinton gave Brenda Humes an information sheet prepared by himself. This written material included language that "pregnancies are rare" and that the IUD "should be changed about every 15 months." Another sheet of information prepared by Dr. Clinton and given to Brenda Humes instructed her to replace
Page 1035
the IUD before 16 months because the "progesterone runs out by this time."6. Dr. Clinton told Brenda Humes that none of his patients had ever gotten pregnant while using the IPCS and that she would not get pregnant using the IPCS for at least fifteen months.
7. Dr. Clinton admitted that ALZA informed him pregnancy could occur with the IPCS.
8. Brenda Humes followed the advice of Dr. Clinton concerning the length of time she could use the IUD for contraception. On or about August 6, 1986, or fourteen months after Brenda Humes had had the IUD inserted, she became pregnant. Her pregnancy was confirmed on September 6, 1986, by Henry Buck, M.D.
9. Brenda Humes' pregnancy was complicated by the presence of the IPCS which exposed her to increased risk of infection, spontaneous abortion, septic shock, and death.
10. Brenda Humes suffered pain and bleeding throughout the term of her pregnancy with the IUD in place.
11. For strong medical considerations, Dr. Buck recommended that Brenda Humes terminate her pregnancy.
[246 Kan. 593] 12. On November 4, 1986, after being advised on numerous occasions that there were substantial life-threatening risks in continuing the pregnancy, Brenda Humes underwent a therapeutic abortion. The fetus was sixteen and one-half weeks and could not have survived outside the mother's body at that time. Thus, the fetus was nonviable.
13. Since the abortion, Brenda Humes has suffered continued physical and psychological distress. She is presently diagnosed as suffering from pelvic inflammatory disease, post-traumatic stress disorder, and post-abortion syndrome.
Additional facts will be presented where pertinent to a proper explanation of the case.
The first issue we consider is whether the district court erred in ruling that Brenda and Bennie Humes could maintain wrongful death and survival actions on behalf of an unborn, nonviable fetus. Dr. Clinton and ALZA contend these actions are not proper as a matter of law because no cause of action may be brought on behalf of an unborn, nonviable fetus.
Under this state's wrongful death statute, the personal representative of a person killed by the wrongful act or omission of another may maintain an action for damages resulting from the negligent act if the decedent might have maintained the action had he or she lived. K.S.A. 60-1901. Thus, our ultimate inquiry is whether an unborn, nonviable fetus is a "person" within the meaning of the wrongful death statute.
At common law, the courts did not recognize a right of action for prenatal personal injuries. Scott v. McPheeters, 33 Cal.App.2d 629, 635, 92 P.2d 678 (1939). In 1884, Justice Holmes, speaking for the Supreme Judicial Court of Massachusetts, held that a child en ventre sa mere had no jurisdictional existence; that is, the unborn fetus was so intimately united with its mother that no separate right of action could accrue to the unborn fetus. Dietrich v. Northampton, 138 Mass. 14 (1884). The Dietrich holding remained substantially unchallenged until 1946, when a United States District Court allowed recovery for a child born alive who had sustained prenatal injuries while viable. Bonbrest v. Kotz, 65 F.Supp. 138 (D.D.C.1946). Minnesota was the first state to allow a wrongful death action on behalf of a stillborn child who [246 Kan. 594] sustained injuries while viable. Verkennes v. Corniea, 229 Minn. 365, 38 N.W.2d 838 (1949).
Following the Verkennes decision, other states began to adopt the view that a wrongful death action would lie when an independent life in being was negligently injured by the wrongful act of another; however, these early cases usually limited recovery to children who survived birth. Keyes v. Construction Service, Inc., 340 Mass. 633, 165 N.E.2d 912 (1960); Carroll v. Skloff, 415 Pa. 47, 202 A.2d 9 (1964); Simmons v. Weisenthal, 29 Pa.D. & C.2d
Page 1036
54 (1962); Hall v. Murphy, 236 S.C. 257, 113 S.E.2d 790 (1960).More recently, some courts have expressed a view that an action may be maintained for prenatal injuries negligently inflicted at any stage of gestation, provided the child is born alive. Group Health Ass'n v. Blumenthal, 295 Md. 104, 117-19, 453 A.2d 1198 (1983); Annot., 40 A.L.R.3d 1222, 1230 § 3[a]. In such cases, it is reasoned that viability--the ability to live independently of the mother--is an irrelevant demarcation when a child survives prenatal injuries and is born with damages suffered within the womb. Other courts reason it is incongruous to recognize an unborn fetus as alive and capable of inheriting, but to reject it as capable of...
To continue reading
Request your trial-
State ex rel. Johnson & Johnson v. Karl, No. 33211.
...there is no duty on the part of manufacturers of prescription drugs to directly warn patients."); Syl. pt. 5, in part, Humes v. Clinton, 246 Kan. 590, 792 P.2d 1032 (1990) ("Manufacturers of prescription drugs have a duty to warn of dangerous side effects and risks associated with the use o......
-
In re Norplant Contraceptive Products Liability Litigation, No. 1:95-CV-5360.
...398, 400 (Del.1989); Ortho Pharmaceutical Corp. v. Chapman, 180 Ind.App. 33, 388 N.E.2d 541, 548-49, 553, 557 (1979); Humes v. Clinton, 246 Kan. 590, 792 P.2d 1032, 1040 (Kan.1990); Rhoto v. Ribando, 504 So.2d 1119, 1123 (La.Ct.App. 1987); Seley v. G.D. Searle & Co., 67 Ohio St.2d 192, 423 ......
-
Gourdine v. Crews, No. 134 September Term, 2007.
...594, 595 (2003); Kirk v. Michael Reese Hosp. & Med. Ctr., 117 Ill.2d 507, 111 Ill.Dec. 944, 513 N.E.2d 387, 393 (1987); Humes v. Clinton, 246 Kan. 590, 792 P.2d 1032 (1990); Larkin v. Pfizer, Inc., 153 S.W.3d 758, 770 (Ky.2004); Wyeth Labs., Inc. v. Fortenberry, 530 So.2d 688, 691 (Miss.198......
-
Land v. Midwest Office Technology, Inc., No. 96-4115-SAC.
...for emotional distress caused by the negligence of another unless accompanied by or resulting in physical injury." Humes v. Clinton, 246 Kan. 590, 598, 792 P.2d 1032(1990) (citing cases); See, e.g., Schweitzer-Reschke v. Avnet, Inc., 874 F.Supp. 1187, 1196 (D.Kan.1995). Generalized physical......
-
State ex rel. Johnson & Johnson v. Karl, No. 33211.
...there is no duty on the part of manufacturers of prescription drugs to directly warn patients."); Syl. pt. 5, in part, Humes v. Clinton, 246 Kan. 590, 792 P.2d 1032 (1990) ("Manufacturers of prescription drugs have a duty to warn of dangerous side effects and risks associated with the use o......
-
In re Norplant Contraceptive Products Liability Litigation, No. 1:95-CV-5360.
...398, 400 (Del.1989); Ortho Pharmaceutical Corp. v. Chapman, 180 Ind.App. 33, 388 N.E.2d 541, 548-49, 553, 557 (1979); Humes v. Clinton, 246 Kan. 590, 792 P.2d 1032, 1040 (Kan.1990); Rhoto v. Ribando, 504 So.2d 1119, 1123 (La.Ct.App. 1987); Seley v. G.D. Searle & Co., 67 Ohio St.2d 192, 423 ......
-
Gourdine v. Crews, No. 134 September Term, 2007.
...594, 595 (2003); Kirk v. Michael Reese Hosp. & Med. Ctr., 117 Ill.2d 507, 111 Ill.Dec. 944, 513 N.E.2d 387, 393 (1987); Humes v. Clinton, 246 Kan. 590, 792 P.2d 1032 (1990); Larkin v. Pfizer, Inc., 153 S.W.3d 758, 770 (Ky.2004); Wyeth Labs., Inc. v. Fortenberry, 530 So.2d 688, 691 (Miss.198......
-
Miller v. Pfizer Inc. (Roerig Division), Civil Action No. 99-2326-KHV.
...based upon the theory that the physician acts as a learned intermediary between the drug manufacturer and the patient." Humes v. Clinton, 246 Kan. 590, 600, 792 P.2d 1032, 1039 (1990). Because "prescription drugs are available only to a physician, it is the physician's duty to inform himsel......